Jan 14, 2021 01:34 AM (GMT+8)
Recently, the European Commission approved the commercial use of an artificial heart made by French company carmat. According to the company, the product is made of biomaterials compatible with human body, and can complete human heart function under battery power supply, which is expected to alleviate the shortage of heart donors and bring good news to patients who need heart transplantation. The artificial heart is tentatively priced at 150000 euro (contract 1.18 million RMB), and the production capacity can reach 10 pieces per month according to the market demand.
This text is a result of machine translation.